NCT02945007View on ClinicalTrials.gov

A Study to Assess the Relative Oral Bioavailability of a Single Dose of JNJ-53718678 Administered as Oral Concept Formulation Compared to the Current Oral Solution and to Assess the Effect of Food on the Pharmacokinetics of Oral Concept Formulation

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 8, 2016

Primary Completion Date

January 16, 2020

Study Completion Date

January 16, 2020

Conditions

Healthy

Interventions

DRUG

JNJ-53718678

Participants will receive JNJ-53718678 under fed or fasted conditions.

Trial Locations (1)

Unknown

Merksem

All Listed Sponsors

lead

Janssen Research & Development, LLC

INDUSTRY

NCT02945007 - A Study to Assess the Relative Oral Bioavailability of a Single Dose of JNJ-53718678 Administered as Oral Concept Formulation Compared to the Current Oral Solution and to Assess the Effect of Food on the Pharmacokinetics of Oral Concept Formulation | Biotech Hunter | Biotech Hunter